BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19400699)

  • 1. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer.
    McCullough ML; Bostick RM; Mayo TL
    Annu Rev Nutr; 2009; 29():111-32. PubMed ID: 19400699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
    Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
    Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of vitamin D receptor (VDR), CYP27B1 and CYP24A1 genes and the risk of colorectal cancer.
    Vidigal VM; Silva TD; de Oliveira J; Pimenta CAM; Felipe AV; Forones NM
    Int J Biol Markers; 2017 May; 32(2):e224-e230. PubMed ID: 28009432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
    Wu X; Cheng J; Yang K
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk.
    Dong LM; Ulrich CM; Hsu L; Duggan DJ; Benitez DS; White E; Slattery ML; Farin FM; Makar KW; Carlson CS; Caan BJ; Potter JD; Peters U
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2540-8. PubMed ID: 19706847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor polymorphisms and cancer.
    Gandini S; Gnagnarella P; Serrano D; Pasquali E; Raimondi S
    Adv Exp Med Biol; 2014; 810():69-105. PubMed ID: 25207361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
    Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
    Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Vitamin D3 metabolism in prostate cancer.
    Lou YR; Qiao S; Talonpoika R; Syvälä H; Tuohimaa P
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):317-25. PubMed ID: 15663995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.
    Epstein MM; Andrén O; Kasperzyk JL; Shui IM; Penney KL; Fall K; Rider JR; Stampfer MJ; Andersson SO; Giovannucci E; Mucci LA
    Cancer Causes Control; 2012 Aug; 23(8):1359-66. PubMed ID: 22710747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
    Clendenen TV; Ge W; Koenig KL; Axelsson T; Liu M; Afanasyeva Y; Andersson A; Arslan AA; Chen Y; Hallmans G; Lenner P; Kirchhoff T; Lundin E; Shore RE; Sund M; Zeleniuch-Jacquotte A
    PLoS One; 2015; 10(10):e0140478. PubMed ID: 26488576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.
    Schäfer A; Emmert S; Kruppa J; Schubert S; Tzvetkov M; Mössner R; Reich K; Berking C; Volkenandt M; Pföhler C; Schön MP; Vogt T; König IR; Reichrath J
    Arch Dermatol Res; 2012 Jul; 304(5):353-61. PubMed ID: 22576141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
    de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
    Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
    BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.
    Simon KC; Munger KL; Xing Yang ; Ascherio A
    Mult Scler; 2010 Feb; 16(2):133-8. PubMed ID: 20007432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D pathway gene variants and prostate cancer risk.
    Holt SK; Kwon EM; Peters U; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1929-33. PubMed ID: 19454612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of vitamin D metabolism genes and serum level of vitamin D in colorectal cancer.
    Marques Vidigal V; Aguiar Junior PN; Donizetti Silva T; de Oliveira J; Marques Pimenta CA; Vitor Felipe A; Manoukian Forones N
    Int J Biol Markers; 2017 Oct; 32(4):e441-e446. PubMed ID: 28665452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
    Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.